A detailed history of Klp Kapitalforvaltning As transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 34,800 shares of NBIX stock, worth $4.07 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
34,800
Holding current value
$4.07 Million
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$111.62 - $139.44 $3.88 Million - $4.85 Million
34,800 New
34,800 $4.75 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.2B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Klp Kapitalforvaltning As Portfolio

Follow Klp Kapitalforvaltning As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klp Kapitalforvaltning As, based on Form 13F filings with the SEC.

News

Stay updated on Klp Kapitalforvaltning As with notifications on news.